Award
Delivery Order #SPE2D226F1643
Delivery Order for Erythromycin Ophthalmic Supply to Government
Buyer
Defense Logistics Agency
Award Amount
$63.00
Ceiling
$63.00
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 16, 2026
Identifier
SPE2D226F1643
NAICS
325411
This award represents a delivery order contract issued under an existing indefinite delivery vehicle (IDV) with DMS Pharmaceutical Group Inc., a prominent pharmaceutical manufacturer and distributor. The delivery order specifically procures erythromycin ophthalmic medication, a critical antibiotic preparation intended to prevent or treat eye infections. This contract extends the supply capabilities previously established in the parent IDV, supporting continued governmental healthcare initiatives by ensuring timely access to essential pharmaceutical products. The scope of work involves the specific procurement and delivery of erythromycin ophthalmic formulations for use within government medical settings. The contract was awarded under the umbrella of a long-term, competitively bid IDV that DMS Pharmaceutical Group secured, reinforcing the agency’s commitment to reliable pharmaceutical supply chains. The limited period of performance for this delivery order corresponds to the fulfillment date of the order, embedded within the comprehensive multi-year IDV beginning in mid-2025. This contract is vital for sustaining effective public health interventions by maintaining the availability of necessary medications.
Description
8511978823!ERYTHROMYCIN OPHTHA